CTOs on the Move

MEDJET Assistance

www.medjetassistance.com

 
MEDJET Assistance is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Silk Road Medical

Silk Road Medical believes that by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with arterial disease. Our history is one of deep collaboration with vascular surgeons and our future will be guided by continuous learning, observation, and improvement. Silk Road advances patient care.

Business Health Services

Business Health Services is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WiserTogether

WiserTogether`s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers and providers. The company serves over 3 million people through their employers and health plans.

Rockford Health System

Rockford Health System is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.